Two months after naming an interim finance chief, LifeVantage has selected a candidate to fill the position on a permanent basis.
The wellness company said Steven R. Fife will succeed Gary Koos as Chief Financial Officer. Fife hails from Evidera, the Maryland-based research firm that was acquired last fall by Pharmaceutical Product Development. For two years leading up to the sale, Fife served as CFO and COO of the private equity-backed firm, leading multiple international teams.
“Attracting someone of Steve’s caliber is a testament to the opportunities available at LifeVantage,” said Darren Jensen, LifeVantage President and CEO. “Not only does he have substantial public company experience, he brings a diverse financial perspective, with experience with high-growth companies, cost saving initiatives, redesigns of internal productivity systems and establishing strong environments of processes and controls.”
The new CFO brings more than three decades of experience in accounting and finance roles, beginning with a stint at Deloitte & Touche. In recent years Fife has filled the CFO post at publicly traded companies such as Active Power Inc. and LECG Corp. He joins LifeVantage just days after Charles Wach, who was named Chief Operating Officer earlier this month.
